Effect of Filgotinib on Body Mass Index (BMI) and Effect of Baseline BMI on the Efficacy and Safety of Filgotinib in Rheumatoid Arthritis

Effect of Filgotinib on Body Mass Index (BMI) and Effect of Baseline BMI on the Efficacy and Safety of Filgotinib in Rheumatoid Arthritis

Abstract Introduction This post hoc analysis of the phase 3 rheumatoid arthritis (RA) filgotinib clinical trial program assessed the effect of filgotinib on body mass index (BMI) in patients with RA and the impact of BMI on the efficacy and safety of filgotinib. Methods FINCH 1–3 were randomized, do...

Full description

Bibliographic Details
Main Authors: Alejandro Balsa, Siegfried Wassenberg, Yoshiya Tanaka, Anne Tournadre, Hans-Dieter Orzechowski, Vijay Rajendran, Udo Lendl, Pieter-Jan Stiers, Chris Watson, Roberto Caporali, James Galloway, Patrick Verschueren
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-09-01
Series:Rheumatology and Therapy
Subjects:
Body mass index
Clinical trial
DMARD
Filgotinib
Interventional study
JAK inhibitor
Online Access:https://doi.org/10.1007/s40744-023-00599-1

Internet

https://doi.org/10.1007/s40744-023-00599-1

Similar Items